Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).

被引：0

作者：

Wu, Linda

Fulgenzi, Claudia A. M.

D'Alessio, Antonio

Chon, Hong Jae

Kudo, Masatoshi

Schonlein, Martin

von Felden, Johann

Wietharn, Brooke

Phen, Samuel

Scheiner, Bernhard

Balcar, Lorenz

Huang, Yi-Hsiang

Pressiani, Tiziana

Masi, Gianluca

Naqash, Abdul Rafeh

Bettinger, Dominik

Vogel, Arndt

Galle, Peter R.

Gaillard, Vince

Ang, Celina

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[2] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England

[3] Imperial Coll, London, England

[4] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Med Oncol, Seongnam, South Korea

[5] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan

[6] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 2, Hamburg, Germany

[7] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany

[8] Univ Kansas, Sch Med, Kansas City, KS USA

[9] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA

[10] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[11] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[12] Taipei Vet Gen Hosp, Bei Tou Qu, Taiwan

[13] Ist Clin Humanitas, Humanitas Canc Ctr, Rozzano, Italy

[14] Univ Pisa, Pisa, Italy

[15] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK USA

[16] Univ Freiburg, Fac Med, Freiburg Univ,Med Ctr, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Freiburg, Germany

[17] Hannover Med Sch, Hannover, Germany

[18] Univ Med Ctr Mainz, Mainz, Germany

[19] Roche, Basel, Switzerland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

504

引用

页码：504 / 504

页数：1

共 50 条

[1] Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Wu, Yue Linda
Fulgenzi, Claudia Angela Maria
D'Alessio, Antonio
Cheon, Jaekyung
Nishida, Naoshi
Saeed, Anwaar
Wietharn, Brooke
Cammarota, Antonella
Pressiani, Tiziana
Personeni, Nicola
Pinter, Matthias
Scheiner, Bernhard
Balcar, Lorenz
Huang, Yi-Hsiang
Phen, Samuel
Naqash, Abdul Rafeh
Vivaldi, Caterina
Salani, Francesca
Masi, Gianluca
Bettinger, Dominik
Vogel, Arndt
Schoenlein, Martin
von Felden, Johann
Schulze, Kornelius
Wege, Henning
Galle, Peter R.
Kudo, Masatoshi
Rimassa, Lorenza
Singal, Amit G.
Sharma, Rohini
Cortellini, Alessio
Gaillard, Vincent E.
Chon, Hong Jae
Pinato, David J.
Ang, Celina
CANCERS, 2022, 14 (23)
[2] The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Wang, Jing-Houng
Chen, Yen-Yang
Kee, Kwong-Ming
Wang, Chih-Chi
Tsai, Ming-Chao
Kuo, Yuan-Hung
Hung, Chao-Hung
Li, Wei-Feng
Lai, Hsiang-Lan
Chen, Yen-Hao
CANCERS, 2022, 14 (02)
[3] Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma
de Jong, Mechteld C.
Mihai, Radu
Khan, Shahab
WORLD JOURNAL OF SURGERY, 2021, 45 (03) : 754 - 764
[4] Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma
Mechteld C. de Jong
Radu Mihai
Shahab Khan
World Journal of Surgery, 2021, 45 : 754 - 764
[5] Predictive value of Neutrophil-to-lymphocyte ratio(NLR) and Platelet-to-lymphocyte ratio(PLR) in patients with Sarcoidosis
Yalniz, Enver
Ucsular, Fatma
Karadeniz, Gulistan
Polat, Gulru
Vayisoglu, Gorkem
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[6] The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
Maloney, Sarah
Pavlakis, Nick
Itchins, Malinda
Arena, Jennifer
Mittal, Anubhav
Hudson, Amanda
Colvin, Emily
Sahni, Sumit
Diakos, Connie
Chan, David
Gill, Anthony J.
Samra, Jaswinder
Clarke, Stephen J.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
[7] Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma
Li, Chuan
Wen, Tian-Fu
Yan, Lu-Nan
Li, Bo
Wang, Wen-Tao
Yang, Jia-Yin
Xu, Ming-Qing
JOURNAL OF SURGICAL RESEARCH, 2015, 198 (01) : 73 - 79
[8] Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in Meniere's disease and vestibular neuritis
Quaranta, Nicola A. A.
Salzo, Anna E.
Pontillo, Vito
Scarano, Emanuele
Sergi, Bruno
Picciotti, Pasqualina M.
HEARING BALANCE AND COMMUNICATION, 2021, 19 (04) : 235 - 239
[9] Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) Can Predict Spontaneous Preterm Birth?
Yuce, Ebru
JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 2423 - 2429
[10] Evaluating the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic and treatment response biomarkers in stage IV colorectal cancer patients
Allahyari, Abolghasem
Fallah, Fahime
Taqanaki, Pegah Bahrami
Tafti, Seyyed Pouria
Vakilzadeh, Mohammad Moein
Nodeh, Mohammad Moeini
Kamandi, Mostafa
Noferesti, Alireza
ONCOLOGY IN CLINICAL PRACTICE, 2024,

← 1 2 3 4 5 →